v3.26.1
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows used in operating activities:    
Net loss $ (2,496,540) $ (3,845,380)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 555 5,517
Equity-based compensation 252,364 548,765
Changes in operating assets and liabilities:    
Interest receivable (370) 13,489
Prepaid expenses (227,931) (533,348)
Deferred offering costs (7,265) 5,994
Accounts payable 174,146 (224,066)
Accrued liabilities (697,176) (619,726)
Net cash used in operating activities (3,002,217) (4,648,755)
Cash flows used in investing activities:    
Investment in property and equipment (3,251)
Net cash used in investing activities (3,251)
Cash flows from financing activities:    
Proceeds from sale of common stock under ATM 1,366,535 2,055,471
Issuance costs for sale of common stock under ATM (63,970) (85,335)
Net cash provided by financing activities 1,302,565 1,970,136
Net change in cash and cash equivalents (1,699,652) (2,681,870)
Cash and cash equivalents – beginning of the period 4,007,789 10,017,942
Cash and cash equivalents – end of the period $ 2,308,137 $ 7,336,072